<DOC>
	<DOCNO>NCT02179463</DOCNO>
	<brief_summary>RATIONALE : Neoadjuvant chemotherapy prove effective locally advanced gastric cancer , yet best pattern response evaluation remain unknown . PURPOSE : Compare different pattern response evaluation Gastric Cancer .</brief_summary>
	<brief_title>Compare Different Response Evaluations Neoadjuvant Chemotherapy Gastric Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Find best pattern response evaluation gastric cancer . II . Assess factor associate pattern . OUTLINE : Neoadjuvant chemotherapy . PROJECTED ACCRUAL : Up 150 patient accrue approximately 2 year .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>sign write informed consent form age ≥ 18 year pathologically confirm gastric GEJ adenocarcinoma disease clinical stage locally advanced gastric cancer CT/EUS ( cT2+NanyM0 ) No prior antitumor treatment allow , include chemotherapy , radiotherapy , immune therapy target therapy Adequate organ function define : Hematologic ANC ≥ 1.5*109/l Hemoglobin ≥ 9 g/dl Platelets ≥ 100*109/l Hepatic Albumin ≥ 30g/l Serum bilirubin ≤ 1.5×ULN AST ALT ≤ 2.5×ULN ALP ≤ 2.5×ULN TBIL ≤ 1.5×ULN Renal Serum Creatinine &lt; 1.5 ULN KPS ≥ 70 Adequate lung heart function Negative serum urine pregnant test within 7 day prior randomization childbearing age woman Sexually active male female willing practice contraception study 30 day end study . Refuse provide blood/tissue sample； With distant metastasis diagnose CT/EUS； Sexually active male female refuse practice contraception study 30 day end study . History organ transplantation（including autologous bone marrow transplantation Peripheral stem cell transplantation）； Prior long term steroid therapy ( exclude short term steroid treatment complete prior &gt; 2 week study enrollment ) ； Patients central nervous system ( CNS ) disorder peripheral nervous system disorder psychiatric disease； Concurrent severe infection； Concurrent disease condition would make subject inappropriate study participation serious medical disorder would interfere subject 's safety ( include current active hepatic , biliary , renal , respiratory disease , uncontrolled diabetes hypertension et al ) ； History malignancy . However , subject diseasefree 5 year , subject history completely resect nonmelanoma skin cancer successfully treat situ carcinoma , eligible； Known history uncontrolled symptomatic angina , uncontrolled arrhythmia hypertension , congestive heart failure , cardiac infarction within 6 month prior study enrollment , cardiac insufficiency； Person capacity ( legally ) inappropriate continue study treatment ethics/medical reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Gastric Cancer</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Response Evaluation</keyword>
</DOC>